Vor Biopharma Stock Forecast

Stock Price Forecast

The 9 analysts that cover Vor Biopharma stock have a consensus rating of "Buy" and an average price target of $45.33, which forecasts a 173.24% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $120.

Price Target: $45.33 (+173.24%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$8.00	$45.33	$40	$120
Change	-51.78%	+173.24%	+141.11%	+623.33%

Analyst Ratings

The average analyst rating for Vor Biopharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	3	4	4	4	4
Buy	2	3	3	3	3	3
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	9	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $32 → $31	Strong Buy	Maintains	$32 → $31	+86.86%	Apr 15, 2026
Martin Fan Wedbush	Wedbush	Hold Maintains $9 → $15	Hold	Maintains	$9 → $15	-9.58%	Mar 31, 2026
Farzin Haque Jefferies	Jefferies	Strong Buy Initiates $50	Strong Buy	Initiates	$50	+201.39%	Mar 30, 2026
Sadia Rahman Wells Fargo	Wells Fargo	Buy Initiates $30	Buy	Initiates	$30	+80.83%	Mar 19, 2026
Geoff Meacham Citigroup	Citigroup	Strong Buy Initiates $50	Strong Buy	Initiates	$50	+201.39%	Jan 9, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-4.31

from -70.50

EPS Next Year

-4.34

from -4.31

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-41.95	-46.57	-35.08	-34.03	-70.50	-4.31	-4.34
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-2.33	-1.24
Avg	-4.31	-4.34
Low	-7.64	-8.18

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.